Progression and perspectives in disease modeling for Juvenile myelomonocytic leukemia
2025

Understanding Juvenile Myelomonocytic Leukemia (JMML) and Its Research Models

publication Evidence: moderate

Author Information

Author(s): Fu Shengyuan, Guo Yao, Peng Zhiyong, Zhang Dengyang, Chang Zhiguang, Xiao Yan, Zhang Qi, Yu Liuting, Chen Chun, Chen Yun, Zhao Yuming

Primary Institution: The Seventh Affiliated Hospital, Sun Yat-sen University

Hypothesis

The study aims to explore various experimental models for understanding JMML and their implications for treatment.

Conclusion

The review highlights the need for improved preclinical models to better understand JMML and develop effective treatments.

Supporting Evidence

  • JMML is resistant to conventional chemotherapy, necessitating novel treatment strategies.
  • Current research models include patient-derived cells and genetically engineered mice.
  • Understanding gene mutations in JMML can lead to more precise therapeutic interventions.

Takeaway

Juvenile myelomonocytic leukemia is a rare disease in kids, and scientists are trying to create better models to study it and find new treatments.

Methodology

The review discusses various experimental models including patient-derived cell-based models, cell models, and animal models used in JMML research.

Limitations

The rarity of JMML makes it difficult to collect sufficient primary research material for studies.

Participant Demographics

The disease primarily affects infants and young children.

Digital Object Identifier (DOI)

10.1007/s12032-024-02549-5

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication